# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-20-026832
Filing Date
2020-09-16
Accepted
2020-09-16 07:11:34
Documents
24
Period of Report
2020-09-16

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | REPORT OF FOREIGN PRIVATE ISSUER | ea126896-6k_therapixbio.htm | 6-K | 18061
2 | CORPORATE PRESENTATION OF THERAPIX BIOSCIENCES LTD. DATED SEPTEMBER 2020 | ea126896ex99-1_therapixbio.htm | EX-99.1 | 31848
3 | GRAPHIC | ex99-1_001.jpg | GRAPHIC | 914316
4 | GRAPHIC | ex99-1_002.jpg | GRAPHIC | 549882
5 | GRAPHIC | ex99-1_003.jpg | GRAPHIC | 253636
6 | GRAPHIC | ex99-1_004.jpg | GRAPHIC | 684628
7 | GRAPHIC | ex99-1_005.jpg | GRAPHIC | 357106
8 | GRAPHIC | ex99-1_006.jpg | GRAPHIC | 270456
9 | GRAPHIC | ex99-1_007.jpg | GRAPHIC | 414506
10 | GRAPHIC | ex99-1_008.jpg | GRAPHIC | 436810
11 | GRAPHIC | ex99-1_009.jpg | GRAPHIC | 429758
12 | GRAPHIC | ex99-1_010.jpg | GRAPHIC | 499956
13 | GRAPHIC | ex99-1_011.jpg | GRAPHIC | 385692
14 | GRAPHIC | ex99-1_012.jpg | GRAPHIC | 579974
15 | GRAPHIC | ex99-1_013.jpg | GRAPHIC | 636737
16 | GRAPHIC | ex99-1_014.jpg | GRAPHIC | 445904
17 | GRAPHIC | ex99-1_015.jpg | GRAPHIC | 813645
18 | GRAPHIC | ex99-1_016.jpg | GRAPHIC | 348844
19 | GRAPHIC | ex99-1_017.jpg | GRAPHIC | 243270
20 | GRAPHIC | ex99-1_018.jpg | GRAPHIC | 246906
21 | GRAPHIC | ex99-1_019.jpg | GRAPHIC | 510642
22 | GRAPHIC | ex99-1_020.jpg | GRAPHIC | 727538
23 | GRAPHIC | ex99-1_021.jpg | GRAPHIC | 419179
24 | GRAPHIC | ex99-1_022.jpg | GRAPHIC | 116161
| Complete submission text file | 0001213900-20-026832.txt |  | 13270651

Mailing Address 16 ABBA HILLEL ROAD RAMAT GAN L3 5250608
Business Address 16 ABBA HILLEL ROAD RAMAT GAN L3 5250608 972-3-6167055
Therapix Biosciences Ltd. (Filer) CIK: 0001611746 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38041 | Film No.: 201177398
SIC: 2834 Pharmaceutical Preparations